Intel and DigitalBridge launch Articul8, a new enterprise GenAI company
Thu 4 Jan 2024
Intel, in partnership with global investment firm DigitalBridge Group, has announced the formation of Articul8.
This new independent company is set to provide enterprise customers with a full-stack Generative AI (GenAI) software platform, offering solutions that ensure data security within the enterprise perimeter and flexible deployment options, including cloud, on-premises, or hybrid models.
Generative AI gets Articul8
Articul8 emerges with intellectual property and technology developed at Intel.
Both Intel and DigitalBridge will remain strategically aligned, focusing on market opportunities and promoting GenAI adoption in enterprises.
Arun Subramaniyan, previously a Vice President and General Manager in Intel’s Data Center and AI Group, has taken on the role of CEO at Articul8.
Pat Gelsinger, CEO of Intel, said: “With its deep AI and HPC domain knowledge and enterprise-grade GenAI deployments, Articul8 is well positioned to deliver tangible business outcomes for Intel and our broader ecosystem of customers and partners.”
DigitalBridge Ventures led the investment in Articul8. Equity stakes were taken by Intel and a group of established venture investors, including Fin Capital, Mindset Ventures, Communitas Capital, GiantLeap Capital, GS Futures, and Zain Group.
Marc Ganzi, CEO of DigitalBridge, said: “Articul8 has built a scalable and easy-to-deploy GenAI software platform … We see GenAI as a pivotal force driving digital infrastructure, and we are pleased to collaborate with Intel to support Articul8’s growth.”
Articul8’s vertically-optimised GenAI software platform is optimised for Intel hardware architectures, but supports various hybrid infrastructure alternatives.
The platform has been deployed by clients such as Boston Consulting Group (BCG) in sectors like financial services, aerospace, semiconductors, and telecommunications.
Rich Lesser, Global Chair of BCG, said: “Our collaboration began nearly two years ago … Since then, we have deployed Articul8 products for multiple clients seeking production-ready platforms with rapid time to market.”
As an independent entity backed by industry investment, Articul8 is poised to accelerate its market strategy and expand its product offerings within the GenAI ecosystem.